Cosmecca Korea - Public Comps and Valuation Multiples

Cosmecca Korea Overview

About Cosmecca Korea

Cosmecca Korea Co Ltd is engaged in research, development, and production of cosmetics. It offers various products including skincare, makeup products, and functional products. The skincare products consist of Cream, Essence, Cleansers, Korean herbal products, Exfoliators, and mask sheets. Its functional products comprise of skincare products with specific functions such as UV blocking, brightening, and wrinkle care. The Makeup products range comprise of BB & CC cream, Skin cover balms, Makeup base, Foundation, Concealer, Lipstick, Mascara, and Powders.

Founded

1999

HQ

Employees

450

Website

cosmecca.com

Sectors

Health & Beauty

Financials

LTM Revenue $397M

LTM EBITDA $62.8M

EV

$545M

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

Cosmecca Korea Financials

As of September 2025, Cosmecca Korea reported last 12-month revenue of $397M and EBITDA of $62.8M.

In the same period, Cosmecca Korea generated $99.0M in LTM gross profit and $32.0M in net income.

See Cosmecca Korea valuation multiples based on analyst estimates

Cosmecca Korea P&L

In the most recent fiscal year, Cosmecca Korea reported revenue of $367M and EBITDA of $62.0M.

Cosmecca Korea expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Cosmecca Korea valuation multiples based on analyst estimates

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue	$397M	XXX	$367M	XXX	XXX	XXX
Gross Profit	$99.0M	XXX	$87.1M	XXX	XXX	XXX
Gross Margin	25%	XXX	24%	XXX	XXX	XXX
EBITDA	$62.8M	XXX	$62.0M	XXX	XXX	XXX
EBITDA Margin	16%	XXX	17%	XXX	XXX	XXX
EBIT	$50.3M	XXX	$42.2M	XXX	XXX	XXX
EBIT Margin	13%	XXX	12%	XXX	XXX	XXX
Net Profit	$32.0M	XXX	$29.9M	XXX	XXX	XXX
Net Margin	8%	XXX	8%	XXX	XXX	XXX
Net Debt	XXX	XXX	$42.2M	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for Cosmecca Korea including revenue, profitability, and margin analysis across different time periods. The company reported last twelve months revenue of $397M. EBITDA for the last twelve months was $62.8M. In the most recent fiscal year, Cosmecca Korea achieved $367M in revenue and $62.0M in EBITDA.
Financial Metric	Last Twelve Months (LTM)	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2025)	Next Fiscal Year (2026)	Two Years Forward (2027)
Total Revenue	$397M	Analyst estimates available to subscribers	$367M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	$99.0M	Analyst estimates available to subscribers	$87.1M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	24.9% gross margin	Analyst estimates available to subscribers	23.7% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	$62.8M	Analyst estimates available to subscribers	$62.0M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	15.8% EBITDA margin	Analyst estimates available to subscribers	16.9% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	$50.3M	Analyst estimates available to subscribers	$42.2M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	12.7% EBIT margin	Analyst estimates available to subscribers	11.5% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	$32.0M	Analyst estimates available to subscribers	$29.9M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	8.1% net profit margin	Analyst estimates available to subscribers	8.2% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	Detailed debt information available to subscribers	$42.2M	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for Cosmecca Korea

This financial data table provides comprehensive performance metrics for Cosmecca Korea, a company based in South Korea. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Recent Performance Highlights

Cosmecca Korea generated $397M in revenue over the last twelve months.
The company achieved $62.8M in EBITDA over the last twelve months.
Gross profit for the last twelve months was $99.0M.
Net income over the last twelve months reached $32.0M.

Fiscal Year Performance

In the most recent fiscal year, Cosmecca Korea reported $367M in total revenue.
Fiscal year EBITDA was $62.0M.
The company maintained a gross profit margin of 23.7% in the most recent fiscal year.
EBITDA margin for the fiscal year was 16.9%.
Net profit margin reached 8.2% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for Cosmecca Korea. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

Cosmecca Korea Stock Performance

Cosmecca Korea has current market cap of KRW 679B (or $475M), and EV of KRW 779B (or $545M).

Market Cap Evolution

Cosmecca Korea Stock Data

As of October 17, 2025, Cosmecca Korea's stock price is KRW 63600 (or $45).

See Cosmecca Korea trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$545M	$475M	XXX	XXX	XXX	XXX	$2.89

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Cosmecca Korea Valuation Multiples

Cosmecca Korea's trades at 1.5x EV/Revenue multiple, and 8.8x EV/EBITDA.

See valuation multiples for Cosmecca Korea and 15K+ public comps

Cosmecca Korea Financial Valuation Multiples

As of October 17, 2025, Cosmecca Korea has market cap of $475M and EV of $545M.

Equity research analysts estimate Cosmecca Korea's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Cosmecca Korea has a P/E ratio of 14.8x.

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Market cap (current)	$475M	XXX	$475M	XXX	XXX	XXX
EV (current)	$545M	XXX	$545M	XXX	XXX	XXX
EV/Revenue	1.4x	XXX	1.5x	XXX	XXX	XXX
EV/EBITDA	8.7x	XXX	8.8x	XXX	XXX	XXX
EV/EBIT	10.8x	XXX	12.9x	XXX	XXX	XXX
EV/Gross Profit	5.5x	XXX	n/a	XXX	XXX	XXX
P/E	14.8x	XXX	15.9x	XXX	XXX	XXX
EV/FCF	17.4x	XXX	38.1x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Cosmecca Korea Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Cosmecca Korea Margins & Growth Rates

Cosmecca Korea's last 12 month revenue growth is 12%

Cosmecca Korea's revenue per employee in the last FY averaged $0.8M, while opex per employee averaged $0.1M for the same period.

Cosmecca Korea's rule of 40 is 26% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Cosmecca Korea's rule of X is 45% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Cosmecca Korea and other 15K+ public comps

Cosmecca Korea Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue Growth	12%	XXX	11%	XXX	XXX	XXX
EBITDA Margin	16%	XXX	17%	XXX	XXX	XXX
EBITDA Growth	16%	XXX	18%	XXX	XXX	XXX
Rule of 40	26%	XXX	29%	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	45%	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	$0.8M	XXX	XXX	XXX
Opex per Employee	XXX	XXX	$0.1M	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	2%	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	3%	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	12%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial